News
Children can have mild, moderate, or severe psoriasis. It's a lifelong condition with no cure, but you can treat the symptoms with medication. Most pediatric cases of psoriasis are mild and get ...
Express Scripts, Cigna, UnitedHealthcare, CVS Caremark and Optum Rx are among the payers that have added Yesintek to their ...
Selarsdi, a biosimilar to Stelara, is approved for adult and pediatric psoriatic arthritis, plaque psoriasis, Crohn disease, ...
The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has reported that the FDA has approved the biosimilar treatment ...
Type 1 diabetes is a lifelong condition in which the immune system mistakenly attacks and destroys insulin-producing beta cells in the pancreas. The loss of these cells leads to high blood sugar ...
4d
Pharmaceutical Technology on MSNFDA approves Selarsdi injection as interchangeable with StelaraTeva and Alvotech have announced receipt of the US FDA approval to Selarsdi injection for use as an interchangeable with ...
Why salt therapy is making a real comeback in modern wellness with renewed interest in its respiratory and skin healing ...
US subsidiary and Iceland-based Alvotech (Nasdaq: ALVO) today announced that the US Food and Drug Administration (FDA) has ...
FDA approves Teva and Alvotech's Selarsdi as an interchangeable biosimilar to Stelara, supporting the treatment of multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results